What Trump claimed (and why it drew attention)
In his post, Trump said doctors reported he was in “perfect health,” and that he answered 100% of the questions on a cognitive exam. He also argued that anyone running for president or vice president should be required to take a “meaningful” cognitive test.
The backdrop: bruising, aspirin, and a scan
In a recent interview reported by multiple outlets, Trump attributed bruising on his hands to long-term aspirin use, saying he has taken it for decades and prefers not to reduce the dose. Reuters reported he described taking 325 mg daily rather than a lower “baby aspirin” dose often used in some contexts.
The same reporting noted confusion and commentary around an imaging test: the White House described the October procedure as a preventive CT scan (not an MRI) and said it showed no cardiovascular abnormalities.
Chronic venous insufficiency: what it is in plain English
Separately, the White House has previously confirmed that Trump was diagnosed with chronic venous insufficiency (CVI)—a condition where leg veins have trouble moving blood back toward the heart efficiently. It’s often linked to vein valve issues and can contribute to symptoms like swelling, discomfort, or skin changes over time
Medical sources describe CVI as common—especially with age—and typically manageable, though treatment depends on severity.
Note: This post is informational and based on public reporting; it’s not medical advice.
What we still don’t know
Even with a headline-grabbing “perfect health” statement, several details remain unclear in public reporting:
-
Which cognitive test was administered and under what circumstances (different tools measure different things).
-
What documentation (if any) will be released beyond general statements.
-
Whether any of the reported exams will be presented in a standardized, comparable way over time.
That’s why independent medical details—and how much is publicly disclosed—often matter as much as the headline claims.
Why it matters
Presidential health is always politically charged, but it’s also a governance issue: it affects public confidence, transparency norms, and the broader debate over how the U.S. evaluates candidates’ fitness for office—especially as presidents continue serving at older ages.
If you want, I can also publish a follow-up explainer: “What a cognitive screening actually measures (and what it doesn’t)”—written in a neutral, non-medical-advice way.